U.S. stocks slumped Thursday, a day after minutes of the Federal Reserve’s July meeting showed the central bank was preparing to pull back on its stimulus measures this year and as worries rise over the spread of the delta variant of the coronavirus that causes COVID-19.
What are major indexes doing?
The Dow Jones Industrial Average
fell 141.88 points, or 0.4%, to 34,818.81.
The S&P 500
was down 16.62 points, or 0.4%, at 4,383.65.
The Nasdaq Composite
shed 62.32 points, or 0.4%, to trade at 14,463.59.
On Wednesday, U.S. stocks suffered their worst single session in a month. The Dow fell 382 points, the S&P 500 lost 1.1% and the Nasdaq Composite declined 0.9%.
What’s driving the market?
Investors were rattled by the release of the Fed minutes, even though its message — that tapering of the central bank’s bond purchases will likely start this year — was well choreographed in speeches by policy makers ahead of the release.
Investors remain upbeat about improving corporate earnings, but are growing concerned about the spread of the delta variant of coronavirus and its potential impact on global economic growth at the same as the Fed is talking about tapering its bond buying program.
“While the formula provided could in principle be consistent with a taper decision in September (particularly given the strong July employment report that came after the FOMC meeting), the overall tone of the debate — including multiple references to the delta variant — seem more consistent with a more methodical approach in which the Fed provides a clear signal in September that a taper decision is coming in November. That was and remains our call,” said economists at Evercore ISI.
Also noteworthy was a U.K. study, from the University of Oxford based on real-world data, that showed diminished effectiveness from coronavirus vaccines to the delta variant. After four to five months, the study found that two doses of the vaccine from Pfizer
was as effective as two Oxford-AstraZeneca
“It does seem that the case for caution is growing, whether that be the uncertainty around the timing and pace of the taper or the rising number of delta cases around the world,” said Craig Erlam, senior market analyst at Oanda, in a note.
“The findings from the Oxford study overnight showing a drop in the effectiveness of the vaccine 90 days after the second dose won’t alleviate delta concerns as it spreads rapidly across numerous countries,” he said.
Investors may look past data that showed first-time claims for U.S. unemployment benefits fell more than expected last week to 348,000, a pandemic low. Economists had expected 365,000 initial claims.
The Philadelphia Fed said its manufacturing index fell to 19.4 in August from 21.9 a month earlier.
Which companies are in focus?
Shares of Robinhood Markets Inc.
fell 7% after the online broker’s cautious outlook on the third quarter. See: Robinhood earnings show a company reliant on quieting retail traders and volatile crypto pricing
shares rose 0.9% after the chip maker’s earnings topped Wall Street estimates and the company addressed how supply constraints in the continuing global chip shortage were reflected in its outlook.
What are other markets doing?
The yield on the 10-year Treasury note
fell to 1.22%. Yields fall as bond prices rise.
The ICE U.S. Dollar Index
a measure of the currency against a basket of six major rivals, rose 0.2% and traded at a nine-month high.
Oil futures were on track to extend a losing streak to six sessions, with the U.S. benchmark
down 3.3% at $63.07 a barrel. Gold futures
were lifted 0.4% to $1,791.20 an ounce.